Recombinant Mouse Aven Protein, Myc/DDK-tagged
Cat.No. : | Aven-1790M |
Product Overview : | Purified recombinant protein of mouse full-length apoptosis, caspase activation inhibitor (Aven), with C-terminal MYC/DDK tag, expressed in HEK293T cells. |
- Specification
- Gene Information
- Related Products
- Download
Description : | Biased expression in testis adult (RPKM 40.7), liver E14 (RPKM 4.4) and 13 other tissues |
Source : | HEK293T |
Species : | Mouse |
Tag : | Myc/DDK |
Molecular Mass : | 24.5 kDa |
Purity : | > 80% as determined by SDS-PAGE and Coomassie blue staining |
Stability : | Stable for 12 months from the date of receipt of the product under proper storage and handling conditions. Avoid repeated freeze-thaw cycles. |
Storage : | Store at -80 centigrade after receiving vials. |
Concentration : | >50 μg/mL as determined by microplate BCA method |
Storage Buffer : | 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10% glycerol. |
Gene Name : | Aven apoptosis, caspase activation inhibitor [ Mus musculus (house mouse) ] |
Official Symbol : | Aven |
Synonyms : | AVEN; apoptosis, caspase activation inhibitor; cell death regulator Aven; mAven-L; mAven-S; 1700013A01Rik; 1700056A21Rik; MGC124011 |
Gene ID : | 74268 |
mRNA Refseq : | NM_001165935 |
Protein Refseq : | NP_001159407 |
UniProt ID : | A2AGL5 |
Products Types
◆ Recombinant Protein | ||
AVEN-3034H | Recombinant Human AVEN Protein, MYC/DDK-tagged | +Inquiry |
AVEN-01H | Recombinant Human AVEN Protein, DYKDDDDK-tagged | +Inquiry |
AVEN-4283Z | Recombinant Zebrafish AVEN | +Inquiry |
AVEN-1249C | Recombinant Chicken AVEN | +Inquiry |
AVEN-1041H | Recombinant Human AVEN protein, GST-tagged | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (6)
Ask a questionAVEN has been implicated in the development of some cancers, particularly acute promyelocytic leukemia (APL). The high expression of AVEN is closely related to the pathogenesis of APL.
The activity of AVEN can be modulated by different regulatory mechanisms, including phosphorylation and dephosphorylation, interaction with other proteins, and small molecule regulation. These regulatory mechanisms can affect the function of AVEN.
Potential applications of AVEN in cancer therapy include therapeutic targets, diagnostic markers, and drug development candidates. Drug development for AVEN may help treat certain types of cancer.
It can interact with other members of the Bcl-2 protein family to inhibit the activation of the mitochondrial apoptotic pathway by blocking the activation of the pro-apoptotic proteins Bax and Bak.
The role of AVEN in different types of cells may vary. Its function may be affected by factors such as cell type, tissue, and stage of development.
The expression level of AVEN is regulated by a variety of factors, including transcription factors, epigenetic modifications, and signal transduction pathways. These factors can affect the transcription and translation process of the AVEN gene, thereby regulating its expression level in cells.
Customer Reviews (3)
Write a reviewEndotoxin levels are low and do not interfere with the experimental results.
AVEN is highly expressed and can be easily detected.
It performs well in Western blots, even if stored for a long time, it will not affect its performance.
Ask a Question for All Aven Products
Required fields are marked with *
My Review for All Aven Products
Required fields are marked with *
Inquiry Basket